Can oral dydrogesterone mitigate adverse outcomes with low progesterone on transfer day in natural-cycle frozen embryo transfer?

2026/02/07 by Caroline Roelens, Charlotte Van Overberghe, Fatih Aktoz +6 · 1 voice
Medicine · #Assisted Reproductive Technology and Twin Pregnancy #Ovarian function and disorders #Reproductive Biology and Fertility

paper · doi:10.1016/j.rbmo.2026.105546

openalex publication_date 2026/02/07 · crossref created 2026/02/07 · openalex created_date 2026/02/10 · crossref issued 2026/07/01 · crossref published 2026/07/01 · crossref published-print 2026/07/01 · crossref deposited 2026/07/11 · crossref indexed 2026/07/11 · openalex updated_date 2026/07/13

Discussions

• This new study suggests the potentially deleterious impact from low serum progesterone on the day of blastocyst transfer in NC-FET cycles may be avoided when oral dydrogesterone is administered; suppo [bsky, 0 points, 0 comments]